期刊文献+

倍他乐克联合地高辛对心衰并房颤患者心功能和心室率的影响

Effect of betaloc and digoxin on heart function and ventricular rate in patients with chronic heart failure and atrial fibrillation
下载PDF
导出
摘要 目的:观察倍他乐克联合地高辛对慢性心力衰竭合并心房纤颤患者心功能和心室率的影响。方法:选择慢性心力衰竭合并快速房颤患者62例,随机分成2组。在综合治疗1周后,治疗组32例采用倍他乐克+地高辛治疗;对照组30例,采用地高辛治疗。8周后观察心功能和心室率变化的情况。结果:倍他乐克+地高辛治疗组改善心功能和控制心室率的疗效明显强于地高辛组(P均<0.05)。结论:倍他乐克+地高辛能够改善慢性心力衰竭合并心房纤颤患者的心功能,有效地控制患者较快的心室率,并且安全性高,是其治疗的有效方法。 Objective:To observe the effect of betaloc and digoxin on heart function and ventricular ratc in patients with chronic heart failure (CHF) and atrial fibrillation (AF). Methods: The 32 patients with CHF and quickly AF were randomly divided into treatment group (32 cases ,treated with betaloc and digoxin) and control group (30 cases, treated with digoxin). The effect on heart function and ventricular rate was observed on 56 th day after treatment. Results: The improvements of heart function and heart rate in treatment group were remarkably better than those of control group (P〈0. 05 all). Conclusion: Betaloc and digoxin may improve the clinical heart function and is a safe treatment approach for patients with CHF and AF.
作者 郑爱东
出处 《心血管康复医学杂志》 CAS 2006年第5期478-480,共3页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 倍他乐克 地高辛 心力衰竭 充血性 心房颤动 Betaloc Digoxin Heart failure, congestive Atrial fibrillation
  • 相关文献

参考文献9

二级参考文献59

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1399
  • 2[1]Krahn AD, Manfreda J, Tate RB, et al. The natural history of atrial fibrillation:incidence,risk factors , and prognosis in the Mannitoba Follow-up study [J].Am J Med,1995 ,98 :466-484. 被引量:1
  • 3[2]van den Berg MP,Tuinenberg AE,Crijns HJGM ,et al. Heart failure and atrial fibrillation:current concepts and controversies[J]. Heart,l997,77:309-313. 被引量:1
  • 4[3]Dries DL, Exner DV, Gersh B J, et al. Atrial fibrillation is aasociated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the AOLVD trials. Studies of Left Ventricular Dysfunction[J]. J Am Coll Cardiol, 1998,32: 695 -703. 被引量:1
  • 5[4]The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group. Results of a randomized, placebo-controlled multicentre trial in 239 patients [ J ]. Eur Heart J,1997,18:649-654. 被引量:1
  • 6[5]Hou ZY, Chang MS, Chet CY, et al. Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone [ J ].Eur Heart J,1995,16:521-528. 被引量:1
  • 7[6]Goldenberg IF, Lewis WR, Dias VC, et al. Intravenous diltiazem for the treatment of patients with atrial fibrillation or flutter and modetate to severe congestive cardiac failure[J]. Am J Cardiol, 1994,74:884-889. 被引量:1
  • 8[7]Stambler BS, Wood MA, Ellenbogen KA, et al. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation [J]. Circulation, 1996,94: 1613-1621. 被引量:1
  • 9[8]Varriale P,Sedighi A. Acute management of ateial fibrillation and atrial flutter in the critical care unit:should it be ibutilide[J] ? Clin Cardiol,2000,23:265-268 被引量:1
  • 10[9]van Gelder IC, Crijns HJGM, van Gilst WH, et al. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of. chronic atrial fibrillation and flutter [ J ]. Am J Cardiol, 1991,68:41-46. 被引量:1

共引文献2475

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部